Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-17-005644
Filing Date
2017-05-17
Accepted
2017-05-17 16:56:56
Documents
6
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2016arbutus10-ka.htm 10-K/A 192865
2 EXHIBIT 10.67 REVISED REDACTED ALEXION exhibit1067alexionagreemen.htm EX-10.67 305846
3 EXHIBIT 31.1 Q4 2016 10K/A exhibit311q4201610-ka.htm EX-31.1 13881
4 EXHIBIT 31.2 Q4 2016 10-KA exhibit312q4201610-ka.htm EX-31.2 13867
5 EXHIBIT 32.1 Q4 2016 10KA exhibit321q4201610-ka.htm EX-32.1 6374
6 EXHIBIT 32.2 Q4 2016 10 KA exhibit322q4201610-ka.htm EX-32.2 6715
  Complete submission text file 0001628280-17-005644.txt   540716
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34949 | Film No.: 17852265
SIC: 2834 Pharmaceutical Preparations